April 2017 - Volume 39 - Issue 2
pp: 91-203
Subscribe to eTOC


Comparing Azole Plasma Trough Levels in Lung Transplant Recipients: Percentage of Therapeutic Levels and Intrapatient Variability

Stelzer, Daniela; Weber, Alexandra; Ihle, Franziska; More

Therapeutic Drug Monitoring . 39(2):93-101, April 2017.

Bioequivalence of a New Oral Levosulpiride Formulation Compared With a Standard One in Healthy Volunteers

De Gregori, Simona; Cipollina, Laura; De Silvestri, Annalisa; More

Therapeutic Drug Monitoring . 39(2):118-123, April 2017.

A Time-Dependent Model Describes Methotrexate Elimination and Supports Dynamic Modification of MRP2/ABCC2 Activity

Woillard, Jean-Baptiste; Debord, Jean; Benz-de-Bretagne, Isabelle; More

Therapeutic Drug Monitoring . 39(2):145-156, April 2017.

High Methotrexate Triglutamate Level Is an Independent Predictor of Adverse Effects in Asian Indian Rheumatoid Arthritis Patients—A Preliminary Study

Sandhu, Amit; Dhir, Varun; Bhatnagar, Archana; More

Therapeutic Drug Monitoring . 39(2):157-163, April 2017.

Ex Vivo Model to Decipher the Impact of Extracorporeal Membrane Oxygenation on Beta-lactam Degradation Kinetics

Leven, Cyril; Fillâtre, Pierre; Petitcollin, Antoine; More

Therapeutic Drug Monitoring . 39(2):180-184, April 2017.


Pharmacokinetics and Pharmacogenetics of Selective Serotonin Reuptake Inhibitors During Pregnancy: An Observational Study

Pogliani, Laura; Falvella, Felicia S.; Cattaneo, Dario; More

Therapeutic Drug Monitoring . 39(2):197-201, April 2017.